Navigation Links
Cardium Launches New AWARE Clinical Study Website
Date:6/11/2008

SAN DIEGO, June 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) today announced the launch of a new website at http://www.anginaresearchstudy.com to provide patients, caregivers and physicians with information about the Company's Phase 3 AWARE clinical study. The AWARE study is evaluating the therapeutic effects of Generx(TM) for the potential treatment of myocardial ischemia (insufficient blood flow within the heart muscle) and associated angina due to coronary heart disease. Generx is designed to promote angiogenesis, a natural process of blood vessel growth within the heart muscle, following a one-time intracoronary infusion from a standard cardiac infusion catheter.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The AWARE (Angiogenesis in Women with Angina pectoris who are not candidates for Revascularization) study, a Phase 3 randomized, placebo-controlled, double-blind trial, is planned to enroll approximately 300 women with recurrent stable angina pectoris who are not candidates for revascularization and who are receiving optimal drug therapy. The primary endpoint is the improvement in time to onset of electrocardiogram changes diagnostic of myocardial ischemia during exercise treadmill testing at six months following administration. The secondary endpoints are improvement in myocardial blood flow within the affected heart muscle measured by adenosine SPECT imaging, as well as improvements in other measures of angina. The AWARE study is expected to include up to 50 U.S. clinical centers. Enrollment criteria, participating sites and other info
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
11. Novozymes Launches Enzyme to Reduce Acrylamide in Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015   Mapi expands Pharmacovigilance ... Affairs and global Risk Management strength with the ... announced acquisition . Pharmacovigilance ... a global team that includes physicians, pharmacists, and ... experience in navigating complex safety requirements throughout the ...
(Date:3/31/2015)... 2015 This June 13th, a distinguished ... U.S and International Medical Schools will come together in ... the application of stem cell therapy in treatments and ... and funded by the Ocular Research Symposia Foundation, ... convening intimate meetings of top experts in the field ...
(Date:3/30/2015)... 2015 With recent advancements in residential ... government, major companies are getting into the Solar Energy ... mandates for renewable energy production, many homeowners are looking ... Power is a new solar distribution company in California ... allow qualifying homeowners to enjoy the benefits of solar ...
(Date:3/30/2015)... March 30, 2015  NuGene International, Inc. ("NuGene") ... NuGene BioPharma, Inc. has added another internationally recognized ... Guan is an internationally recognized researcher in bio-inspired ... education at Peking University, China ... the University of North Carolina, Chapel Hill. Following ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3
... 12 ,Abbott ( NYSE: ABT ) and Advanced Medical Optics ... for Abbott to acquire AMO for $22 per share in,cash, ... estimated net debt at the time of closing. Based ... care, comprised of three segments: cataract,surgery, laser vision correction (LASIK), ...
... NEW YORK, Jan. 12 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, ... "the Company"), a leading marketer,distributor and manufacturer of ... the Company will attend and undertake one-on-one,meetings at ... the Pudong,Shangri-La hotel in Shanghai. Management is ...
... at 27th Annual J.P. Morgan Healthcare Conference -REDWOOD CITY, ... GHDX ) announced today that it has initiated ... DX(R) colon cancer assay. Utilizing more than 1,200 ... study will use prospectively defined endpoints to assess the ...
Cached Biology Technology:Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 2Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 3Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 4Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 5Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 6Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO) 7Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 2Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 3Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 4Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 5
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
(Date:3/11/2015)... DUBLIN , Mar. 11, 2015 Research and ... addition of the "Access Control Market by Product, ... to 2020" report to their offering. , ... is expected to reach $10.4 billion by 2020, with ... control market report covers the products types such as ...
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... University, in London, Canada, have developed a CT (Computed Tomography) ... Battista, Chair of the Department of Medical Biophysics at the ... the London Regional Cancer Program at London Health Sciences Centre ... interactive way to teach CT imaging techniques to a wide ...
... Research Institute (OHRI) and the University of Ottawa (uOttawa) has ... (CIHR) and $75,000 from the Stem Cell Network to lead ... cell therapy for septic shock. This deadly condition occurs when ... system, resulting in severe organ damage and death in 30 ...
... Epigenetics is the new hip science. Time Magazine,s front cover ... explains why. Its more explicit subtitle provided the hook - ,The ... change your genes - and those of your kids,. Who ... ways in which the genetic code in our DNA is regulated ...
Cached Biology News:Mini-CT scanner developed as a teaching tool 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 2Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock 3Epigenetics and epidemiology -- hip, hype and science 2Epigenetics and epidemiology -- hip, hype and science 3
... the legendary MSn performance of the LTQ, ... through Thermo Scientifics innovations in ion trap ... the only mass spectrometer that offers multiple ... Pulsed Q Collision Induced Dissociation (PQD) is ...
... Varian, Inc.'s CP-4900 is ... that always delivers the information ... site. When the composition of ... 4th generation micro-Gas Chromatograph generates ...
... Peroxisome Proliferator-Activated Receptor-gamma (PPARGamma) Competitor ... and efficient method for studying ... using fluorescence polarization (FP). The ... domain (PPARGamma-LBD) with an N-terminal ...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
Biology Products: